Filing Flows › Companies › Iovance Biotherapeutics › Timeline
Iovance Biotherapeutics stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+248.4% to $8.04
Iovance Biotherapeutics (IOVA) stock rose 248% over the last 252 sessions, to $8.04. On the way it reported 5 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside), and the company filed 1 material 8-K. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 5, 2026 | Earnings | Earnings: beat the EPS estimate by 41.3% | −11.7% (−7.2% vs SPY) | — | — |
| Aug 6, 2026 | Earnings | Earnings: beat the EPS estimate by 18.4% | +35.8% (+36.0% vs SPY) | +44.0% (+43.7% vs SPY) | +69.5% (+69.1% vs SPY) |
| May 7, 2026 | Earnings | Earnings: missed the EPS estimate by -23.8% | −14.2% (−13.9% vs SPY) | −11.1% (−12.3% vs SPY) | +3.4% (+2.9% vs SPY) |
| Mar 20, 2026 | 8-K | Directors and officers: departures, appointments, pay | −1.6% (−2.7% vs SPY) | −5.0% (−2.7% vs SPY) | +0.3% (−7.9% vs SPY) |
| Feb 24, 2026 | Earnings | Earnings: missed the EPS estimate by -2.1% | +26.8% (+26.1% vs SPY) | +27.1% (+26.5% vs SPY) | +22.5% (+26.7% vs SPY) |
| Nov 6, 2025 | Earnings | Earnings: beat the EPS estimate by 2.8% | +24.4% (+25.5% vs SPY) | +33.9% (+33.0% vs SPY) | +19.5% (+18.3% vs SPY) |
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Iovance Biotherapeutics: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.